Ignite Creation Date:
2024-05-06 @ 3:13 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04564833
Status:
COMPLETED
Last Update Posted:
2024-04-15
First Post:
2020-09-21
Brief Title:
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG andor Cardiac Valve Surgery
Sponsor:
Renibus Therapeutics Inc
Organization:
Renibus Therapeutics Inc
Study Overview
Official Title:
A Phase 2 Double-Blind Randomized Placebo-Controlled Study to Evaluate the Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing Coronary Artery Bypass Graft CABG andor Cardiac Valve Surgery The START Study
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
START
Brief Summary:
The purpose of this study is to evaluate the effect of RBT-1 stannous protoporphyrin SnPPiron sucrose FeS on preconditioning response biomarkers in subjects who are at risk for AKI following cardiac surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None